AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988, S. 2123 and H.R. 5771, The Charitable Giving Tax Deduction Act. H.R. 1337, Legacy IRA Act respecting charitable giving and life income planning, and H.R. 6760, the Protecting Family and Small Business Tax Cuts Act of 2018 respecting the medical expense deduction
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| CAROLINE POWERS | — |
| DENYS C SYMONETTE New | — |
Health Issues HCR
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; H.R. 4122 & S. 2006, the Breast Density & Mammography Reporting Act; and H.R.820 & S.292, the Childhood Cancer STAR Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. The proposed Medical Records Fairness Act (no number yet). Issues regarding the Affordable Care Act premium tax credits and catastrophic plans, HR 6311. Issues regarding protections for people with pre-existing conditions, including S. 3388, HR 6898, and H. Res. 1066. Resolutions to disapprove the short-term rule, H.J. Res 140 and S. J. Res. 63. Advocacy against including the Association Health Plan provision of the House Farm bill in the conference report, H.R. 2 and s. 3042 (section 6004 of the House-passed version of the legislation). Issues involving patient navigation, including the Patient Navigation Assistance Act, HR 6808. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018. H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018. Issues related to caregiving, including H.R. 3759/S. 1028, the RAISE Family Caregivers Act, H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| STEPHANIE KRENRICH | — |
| CAROLINE POWERS | — |
| DENYS C SYMONETTE New | — |
| PHYLICIA L WOODS | — |
Medicare/Medicaid MMM
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479 and regulatory issues related to the Medicare coinsurance issue in these bills; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation. Issues relating to Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial. Issues related to Medicare coverage for BCRA testing and preventive surgery (proposed Murkowski legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| STEPHANIE KRENRICH New | — |
| CAROLINE POWERS | — |
| DENYS C SYMONETTE New | — |
| PHYLICIA L WOODS New | — |
Budget/Appropriations BUD
Federal budget and appropriations for cancer research and programs, including: FY 2019 federal appropriations for the FDA; the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the State/Foreign Operations Appropriations Act; issues relating to global health funding for HPV vaccination and cervical cancer screening and treatment: and issues regarding future work and funding of the CDC tobacco work.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| CAROLINE POWERS | — |
Tobacco TOB
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control as considered in House and Senate, FY18 and The FY19 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273. Issues regarding flavors in tobacco products including e-cigarettes and cigars respecting S.3319, the SAFE Kids Act, and development of similar legislation. Issues relating to trade and investment agreements and tobacco. Issues regarding CDC future funding and work related to tobacco.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSALIE ABBOTT | — |
| OKEYSHA BROOKS-COLEY | — |
| GREGG HAIFLEY | — |
| CAROLINE POWERS | — |
| DENYS C SYMONETTE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.